hydroxyindoleacetic acid has been researched along with oxazolidin-2-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, I; Hergueta, T; Payan, C; Puech, AJ; Robin, L; Thiede, HM; Zimmer, R | 1 |
| Garrick, NA; Linnoila, M; Murphy, DL; Seppala, T | 1 |
1 trial(s) available for hydroxyindoleacetic acid and oxazolidin-2-one
| Article | Year |
|---|---|
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
Topics: Adult; Benzamides; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Psychometrics; Psychophysiology | 1990 |
1 other study(ies) available for hydroxyindoleacetic acid and oxazolidin-2-one
| Article | Year |
|---|---|
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
Topics: Animals; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones | 1985 |